Figure 4
From: IRF5 promotes the proliferation of human thyroid cancer cells
IRF5 protects thyroid cancer cells from the effects of DNA-damaging agents. A. The experiment described in Figure 3 was repeated comparing cell growth before and after exposure to 2 μM Doxorubicin (DOXO) or 5 μg/mL cis-diamminedichloroplatinum (CDDP) (both from Sigma). Columns represent average ± standard deviation of three independent experiments. p-values with 95% confidence intervals were calculated as described in the previous figure (*p < 0.05, **p < 0.01, *** p < 0.001).